These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1490691)

  • 1. alpha-Glucosidase inhibition in the treatment of diabetes mellitus.
    Dimitriadis G; Raptis S
    Horm Metab Res Suppl; 1992; 26():42-9. PubMed ID: 1490691
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitors of alpha-glucosidase].
    Toeller M
    Journ Annu Diabetol Hotel Dieu; 1991; ():203-12. PubMed ID: 1886331
    [No Abstract]   [Full Text] [Related]  

  • 3. Miglitol and hepatotoxicity in type 2 diabetes mellitus.
    Carlson RF
    Am Fam Physician; 2000 Jul; 62(2):315, 318. PubMed ID: 10929699
    [No Abstract]   [Full Text] [Related]  

  • 4. Miglitol for type 2 diabetes mellitus.
    Med Lett Drugs Ther; 1999 May; 41(1053):49-50. PubMed ID: 10368700
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha-glucosidase inhibitors in diabetes. Introduction.
    Kruseman AC; Sels JP; Wolffenbuttel BH
    Eur J Clin Invest; 1994 Aug; 24 Suppl 3():1. PubMed ID: 8001619
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alpha-glucosidase inhibitor for type 2 diabetic patients. Clinical study with miglitol].
    Fehmann HC
    MMW Fortschr Med; 2000 May; 142(21):55. PubMed ID: 10872296
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reducing postprandial glucose levels. Glucosidase antagonists].
    Neye H
    Pharm Unserer Zeit; 2002; 31(3):272-8. PubMed ID: 12071124
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of alpha-inhibitors on blood glucose and insulin levels.
    Laube H; Federlin K; Hillebrand I
    Adv Exp Med Biol; 1988; 246():287-93. PubMed ID: 3074658
    [No Abstract]   [Full Text] [Related]  

  • 9. Type 2 diabetes: glycemic targets and oral therapies for older patients.
    Lardinois CK
    Geriatrics; 1998 Nov; 53(11):22-3, 27-8, 33-4 passim. PubMed ID: 9824974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug therapy of type 2 diabetes: insulin sensitizers improve results].
    Stadler HJ
    Pflege Z; 1999 Nov; 52(11):772-5. PubMed ID: 10788929
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha-glucosidase inhibition as an adjunct to the treatment of type 1 diabetes.
    Tattersall R
    Diabet Med; 1993 Oct; 10(8):688-93. PubMed ID: 8261749
    [No Abstract]   [Full Text] [Related]  

  • 12. Acarbose, an alpha-glucosidase inhibitor for non-insulin-dependent diabetes.
    Welborn TA
    Med J Aust; 1998 Jan; 168(2):76-8. PubMed ID: 9469188
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acarbose in the treatment of non-insulin-dependent diabetes mellitus; a new principle].
    Drent ML; van der Veen EA
    Ned Tijdschr Geneeskd; 1992 Feb; 136(7):308-10. PubMed ID: 1538796
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of the safety and efficacy of acarbose in diabetes mellitus.
    Yee HS; Fong NT
    Pharmacotherapy; 1996; 16(5):792-805. PubMed ID: 8888075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of intestinal alpha glucosidases in the therapy of diabetes mellitus].
    Fölsch UR; Lembcke B
    Internist (Berl); 1991 Dec; 32(12):699-707. PubMed ID: 1823561
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of acarbose, an alpha-glucosidase inhibitor (Bay G 5421), on orally loaded glucose, maltose and sucrose and on blood glucose control in non-insulin-dependent diabetics.
    Hayakawa T; Noda A; Kondo T; Okumura N
    Nagoya J Med Sci; 1985 Jan; 47(1-2):35-41. PubMed ID: 3887176
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic potential of alpha-glucosidase-inhibitors.
    Fölsch UR
    Hepatogastroenterology; 1982 Apr; 29(2):47-8. PubMed ID: 7044933
    [No Abstract]   [Full Text] [Related]  

  • 18. [Risk of complications in the diabetic patient. Postprandial blood glucose peaks as deciding factor].
    MMW Fortschr Med; 2000 Jul; 142(26-27):54-5. PubMed ID: 10929491
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of acarbose on intestinal disaccharidase: review of its therapeutic potential].
    Sternberg A; Wagner Y; Fireman Z
    Harefuah; 1994 May; 126(9):527-9. PubMed ID: 8034269
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acarbose--a new therapeutic principle in diabetes mellitus therapy].
    Schöffling K; Hillebrand I
    Dtsch Med Wochenschr; 1981 Aug; 106(35):1083-4. PubMed ID: 6114844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.